AbbVie Inc (NYSE:ABBV)

AbbVie Inc (NYSE:ABBV) Plans To Keep Allergan’s (NYSE:AGN) Aesthetic Business As An Independent Unit

AbbVie Inc (NYSE:ABBV) and Allergan Plc (NYSE:AGN) have been working on the finer details of their $63 billion merger. The company has come up with an integration plan, and it is planning to keep Allergan’s aesthetic business as an independent unit. AbbVie to keep Allegan Aesthetics as an independent unit The Allergan Aesthetics unit will […]